Osteopontin is Critical for Hyperactive mTOR-Induced Tumorigenesis in Oral Squamous Cell Carcinoma

被引:10
|
作者
Gan, Ning [1 ,2 ,3 ,4 ]
Zou, Sihai [1 ,2 ,3 ]
Hang, Wenming [1 ,2 ,3 ]
Yang, Deqin [1 ,2 ,3 ]
Zhang, Xuemei [4 ]
Yin, Yibing [4 ]
机构
[1] Chongqing Med Univ, Stomatol Hosp, Chongqing 401147, Peoples R China
[2] Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing 401147, Peoples R China
[3] Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing 401147, Peoples R China
[4] Chongqing Med Univ, Minist Educ, Dept Lab Med, Key Lab Diagnost Med, Yixueyuan Rd, Chongqing 400016, Peoples R China
来源
JOURNAL OF CANCER | 2017年 / 8卷 / 08期
基金
中国国家自然科学基金;
关键词
mTOR; ERR alpha; OPN; tumorigenesis; OSCC; MAMMALIAN TARGET; UP-REGULATION; AEROBIC GLYCOLYSIS; SIGNALING PATHWAY; TUMOR-GROWTH; ERR-ALPHA; CANCER; EXPRESSION; PROTEIN; PROGRESSION;
D O I
10.7150/jca.18031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mechanistic target of rapamycin (mTOR) plays a critical role in the development of oral squamous cell carcinoma (OSCC), but the underlying mechanisms remain poorly understood. Here we have demonstrated that the expression of osteopontin (OPN) was dramatically up-regulated in OSCC tissues and cell lines. Moreover, reduction of OPN suppressed cell proliferation, colony formation, and in vivo tumorigenic ability of OSCC cell lines Tca8113. In addition, there was a strong positive correlation between mTORC1 activity and OPN expression in OSCC tissues and cell lines. Furthermore, mTOR complex 1 (mTORC1) enhanced OPN expression through up-regulation of ERR alpha. Therefore, OPN is a downstream target of mTORC1 and is crucial for OSCC development. mTORC1, ERR alpha, and OPN may be potential targets for treatment of OSCC with aberrant mTORC1 signaling.
引用
收藏
页码:1362 / 1370
页数:9
相关论文
共 50 条
  • [41] FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma
    Wen, Qiuyuan
    Alnemah, Mohannad Ma
    Luo, Jiadi
    Wang, Weiyuan
    Chu, Shuzhou
    Chen, Lingjiao
    Li, Jiao
    Xu, Lina
    Li, Meirong
    Zhou, Jianhua
    Fan, Songqing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (07): : 8236 - 8243
  • [42] GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma
    Yang, C. Z.
    Ma, J.
    Zhu, D. W.
    Liu, Y.
    Montgomery, B.
    Wang, L. Z.
    Li, J.
    Zhang, Z. Y.
    Zhang, C. P.
    Zhong, L. P.
    ANNALS OF ONCOLOGY, 2014, 25 (06) : 1215 - 1222
  • [43] Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma
    Sun, Yujuan
    Liu, Nan
    Guan, Xiaobing
    Wu, Hongru
    Sun, Zheng
    Zeng, Hui
    MEDIATORS OF INFLAMMATION, 2016, 2016
  • [44] Genomic Characterization of Esophageal Squamous Cell Carcinoma Reveals Critical Genes Underlying Tumorigenesis and Poor Prognosis
    Qin, Hai-De
    Liao, Xiao-Yu
    Chen, Yuan-Bin
    Huang, Shao-Yi
    Xue, Wen-Qiong
    Li, Fang-Fang
    Ge, Xiao-Song
    Liu, De-Qing
    Cai, Qiuyin
    Long, Jirong
    Li, Xi-Zhao
    Hu, Ye-Zhu
    Zhang, Shao-Dan
    Zhang, Lan-Jun
    Lehrman, Benjamin
    Scott, Alan F.
    Lin, Dongxin
    Zeng, Yi-Xin
    Shugart, Yin Yao
    Jia, Wei-Hua
    AMERICAN JOURNAL OF HUMAN GENETICS, 2016, 98 (04) : 709 - 727
  • [45] Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models
    Ekshyyan, Oleksandr
    Moore-Medlin, Tara N.
    Raley, Matthew C.
    Sonavane, Kunal
    Rong, Xiaohua
    Brodt, Michael A.
    Abreo, Fleurette
    Alexander, Jonathan Steven
    Nathan, Cherie-Ann O.
    BMC CANCER, 2013, 13
  • [46] RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death
    Jiang, Xing-Ran
    Yu, Xi-Ying
    Fan, Jin-Hu
    Guo, Liping
    Zhu, Changjun
    Jiang, Wei
    Lu, Shih-Hsin
    CANCER LETTERS, 2014, 353 (01) : 78 - 86
  • [47] Induced Pluripotent Stem Cell-related Genes Correlate With Poor Prognoses of Oral Squamous Cell Carcinoma
    Muraki, Yumi
    Hasegawa, Takumi
    Takeda, Daisuke
    Ueha, Takeshi
    Iwata, Eiji
    Saito, Izumi
    Amano, Rika
    Sakakibara, Akiko
    Akashi, Masaya
    Komori, Takahide
    ANTICANCER RESEARCH, 2019, 39 (03) : 1205 - 1216
  • [48] Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development
    Chang, Pi-Ling
    Hsieh, Yu-Hua
    Wang, Chao-Cheng
    Juliana, M. Margaret
    Tsuruta, Yuko
    Timares, Laura
    Elmets, Craig
    Ho, Kang-Jey
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 75 (02) : 121 - 132
  • [49] Potential impact of mTOR inhibitors on cervical squamous cell carcinoma: A systematic review
    Assad, Daniele Xavier
    Elias, Silvia Taveira
    Melo, Andreia Cristina
    Ferreira, Carlos Gil
    Canto, Graziela De Luca
    Silva Guerra, Eliete Neves
    ONCOLOGY LETTERS, 2016, 12 (05) : 4107 - 4116
  • [50] Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma
    Hirashima, K.
    Baba, Y.
    Watanabe, M.
    Karashima, R-I
    Sato, N.
    Imamura, Y.
    Nagai, Y.
    Hayashi, N.
    Iyama, K-I
    Baba, H.
    BRITISH JOURNAL OF CANCER, 2012, 106 (05) : 876 - 882